Join DS2 at Outsourcing in Clinical Trials New England 2026
October 27 and 28 at Encore Boston Harbor. The DS2 team is attending both days and holding the breaks open for customers and partners, so if you're going, put a time in with us.
Let's Connect at Encore Boston Harbor
The Cambridge and Boston biotech community turns out for this one, together with the clinical operations and vendor management leaders shaping how their studies get delivered. DS2 supports teams like these every day, and we are looking forward to the two days. If your outsourcing plan is taking shape, we would be glad to talk about the delivery layer. Who builds and ships the kit, who moves the specimen, who holds it at temperature, who keeps the custody record, and how the result gets back to you. We can cover all five, and we would enjoy walking through how.
We often find during these events that the diary fills up quickly. Use the form and we'll block a time for you to meet our team while availability lasts.
Why Attend Outsourcing in Clinical Trials New England 2026?
The eighteenth annual edition, run by Arena International, and this year it doubles as the fiftieth anniversary of the Tufts Center for the Study of Drug Development. Ken Getz opens the conference, and Tufts contributes research across both days, including new benchmarks on sourcing models and their association with trial performance.
700+ attendees across three streams: Arena publishes 700+ attendees, 80+ exhibitors and 50+ speakers across three streams: outsourcing and clinical operations, data and AI and clinical innovation, and biotech strategy.
A room built for delivery: The design point is that everyone in the room is responsible for delivering trials rather than talking about them.
Subject matter worth the trip: The global enrollment crisis, ICH E6(R3) sponsor responsibility and central lab collaboration, risk-based and centralized monitoring, pediatric trial burden, one operating model across multiple CROs, and an industry debate on whether large CRO models really suit small biotechs.
Why Meet with DS2?
Outsourcing strategy answers who is accountable. It does not answer who packs the kit, drives the specimen or holds it at temperature. DS2 does that part, end to end, and hands you the documentation. What we do:
- Diagnostic and specimen collection kit design, assembly and fulfillment
- Kit-to-patient and direct-to-patient distribution
- Medical courier services, including STAT and next-flight-out specimen transport
- Cold chain and temperature-controlled logistics, with the documentation to prove the range held
- Biostorage and biorepository services
- Mobile phlebotomy and specimen collection
- LIS, LIMS and EMR integration, including HL7 and FHIR
- Chain of custody and compliance documentation
Standing up a first program, scaling one across new sites, or bringing several vendors together under one partner. Book a slot and we'll get into the specifics.
Some of Who Is Speaking
From a faculty of more than fifty:
Kenneth Getz
Tufts CSDD
Executive Director and Research Professor, giving the opening keynote
Mary Jo Lamberti, Jennifer Y. Kim, Madison Ford, Hana Do and Maria Florez
Tufts CSDD
Akash Patel
GSK
Senior Director, Head of Design Assurance, on ICH E6(R3) and central lab collaboration
Kelly Butler, JD
Takeda
Ethics and Compliance Partner, Data and Digital Innovation
Julie Solbjerg Appel
Novo Nordisk
Scientific Director
Miguel Valenzuela
Alnylam Pharmaceuticals
Director, Clinical Risk and Analytics
Elaine Shelly
Blueprint Medicine, a Sanofi company
Head of Clinical Outsourcing
Andrea Bottkova and Leonella Seeley
Karyopharm Therapeutics
Running the budgeting workshop
Behtash Bahador
CISCRP
Senior Director, Community Engagement and Partnerships
Thi Doan, PharmD
Novartis
Biomarker Development Postdoctoral Fellow, on pediatric blood draw burden
The full faculty is on the official event page.
The Agenda at a Glance
Three streams run in parallel through both days. The main-stage spine is below. Stream-level detail sits on the official agenda. Sessions move, so check before you plan your day.
Day One · Tuesday, October 27, 2026
Registration and refreshments
Chairperson's opening remarks
Robert Loll, Praxis
Keynote: characterizing the high and rising global enrollment challenge
Kenneth Getz, Tufts CSDD
Keynote panel: agile, feasible and risk-based operating models
Tufts CSDD, US WorldMedsCT and Keenova Therapeutics
Morning refreshments and networking
Stream sessions begin
Outsourcing and clinical operations · Data, AI and clinical innovation · Biotech strategy
Panel: maximizing site productivity, reducing burden and strengthening output
Lunch and networking
New benchmarks on clinical trial sourcing models and trial performance
Mary Jo Lamberti, Tufts CSDD, with Daiichi Sankyo
The changing global pediatric clinical trials landscape
Maria Florez, Tufts CSDD
Ask the experts: sponsor responsibility under ICH E6(R3) and central lab collaboration
Akash Patel, GSK
End of day one and drinks reception
Day Two · Wednesday, October 28, 2026
Tufts 50 Years of Impact breakfast roundtables
Chairperson's opening remarks and early bird prize draw
Robert Loll, Praxis
Workshop: clinical trial negotiation and budgeting
Andrea Bottkova and Leonella Seeley, Karyopharm Therapeutics
Morning refreshments and networking
Recognizing and addressing a global patient enrollment crisis
Madison Ford, Tufts CSDD
Evolving sponsor operating models for risk-based, centralized and AI-enabled monitoring
Tufts CSDD with Novo Nordisk and Alnylam
Lunch and networking
Spotlight on China: navigating China's rise in global clinical development
GlobalData
Closing keynote: spotlight on the FDA, from priorities to patient access
End of conference
Useful Outsourcing in Clinical Trials New England Resources
Outsourcing in Clinical Trials New England 2026 FAQ
General
Fees & registration
Venue & travel
See You at Encore Boston Harbor
Everett, October 27 and 28. Let us know what you would like to cover and we will hold a break.